Patent 9624481 was granted and assigned to Novozymes on April, 2017 by the United States Patent and Trademark Office.
Provided are isolated polypeptides having beta-xylosidase activity and polynucleotides encoding the polypeptides. Also provided are nucleic acid constructs, vectors and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.